Understanding how genetic changes affect T cell cancer treatment
Dissecting the impact of genomic variants on hallmarks of T cell anti-tumor activity
This study is looking at how certain genes in T cells can help them work better against cancers like melanoma and leukemia, with the hope of creating improved treatments for patients who haven't had success with current options.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11070762 on NIH RePORTER |
What this research studies
This research investigates how specific genetic variants in T cells can influence their effectiveness in fighting cancers like melanoma and leukemia. By using advanced techniques such as CRISPR base editing, the team aims to identify and enhance genetic changes that improve T cell activity and persistence in the body. The goal is to develop more effective T cell therapies that can lead to better outcomes for patients who currently do not respond well to existing treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with melanoma or leukemia who are considering or have undergone T cell-based therapies.
Not a fit: Patients with cancers that do not involve T cell therapies or those who are not eligible for such treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective T cell therapies for cancer patients, improving their chances of long-term remission.
How similar studies have performed: Other research has shown promise in enhancing T cell therapies through genetic modifications, indicating that this approach could lead to significant advancements.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Walsh, Zachary Hudson — Columbia University Health Sciences
- Study coordinator: Walsh, Zachary Hudson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.